Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
Rhea-AI Summary
Hoth Therapeutics, Inc. (HOTH) will have its CEO attend the EF Hutton Annual Global Conference in New York, NY. The conference provides networking opportunities and a platform to showcase the company's biopharmaceutical endeavors.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, HOTH declined 2.06%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
To learn more about the EF Hutton Annual Global Conference please visit https://efhutton.com/conference/.
About Hoth Therapeutics, Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life. We are a catalyst in early-stage pharmaceutical research and development, elevating drugs from the bench to pre-clinical and clinical testing. Utilizing a patient-centric approach, we collaborate and partner with a team of scientists, clinicians, and key opinion leaders to seek out and investigate therapeutics that hold immense potential to create breakthroughs and diversify treatment options. To learn more, please visit https://ir.hoththerapeutics.com/ .
Investor Contact:
LR Advisors LLC
Email: investorrelations@hoththerapeutics.com
www.hoththerapeutics.com
Phone: (678) 570-6791
View original content to download multimedia:https://www.prnewswire.com/news-releases/hoth-therapeutics-to-attend-ef-hutton-annual-global-conference-may-15-2024-302132803.html
SOURCE Hoth Therapeutics, Inc.
FAQ
When is the EF Hutton Annual Global Conference?
Who will attend the EF Hutton Annual Global Conference on behalf of Hoth Therapeutics?
Where is the EF Hutton Annual Global Conference taking place?
What is the purpose of Hoth Therapeutics attending the EF Hutton Annual Global Conference?
How can I learn more about the EF Hutton Annual Global Conference?
